Predictive value of the 5-factor modified frailty index for pneumonia in older adults with cervical spinal cord injury.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42547571.
- Also identified by DOI 10.1038/s41393-026-01248-4.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Retrospective cohort study. To examine whether frailty, assessed using the 5-factor modified frailty index (mFI-5), predicts pneumonia and other complications in older adults with cervical spinal cord injury (CSCI). A university-affiliated tertiary care hospital in Japan. Data from 94 adults aged ≥65 years who were treated for CSCI were retrospectively reviewed. Frailty was defined as mFI-5 score ≥2. Patients were classified into frail (mFI-5 ≥ 2) and non-frail (mFI-5 < 2) groups. Logistic regression analyses were performed to evaluate associations between frailty and the incidence of complications, infections, and pneumonia. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Model performance was assessed using receiver operating characteristic analysis. Frailty was identified in 19% of patients. Overall, 45% of patients experienced complications, 37% developed infections, and 23% developed pneumonia. The frail group demonstrated significantly higher rates of complications, infections, and pneumonia compared with the non-frail group. In the multivariate analyses, frailty independently predicted pneumonia (OR: 6.8, 95% CI: 2.0-26) and infections (OR: 8.7, 95% CI: 2.1-45). Frailty, alongside high neurological injury level, was associated with an increased overall risk of complications. Predictive models demonstrated acceptable discriminatory ability for complications and infections. Frailty, assessed using the mFI-5, is an independent predictor of pneumonia and infections in older adults with CSCI. Early assessment of frailty may facilitate perioperative risk stratification, targeted preventive strategies, and informed clinical decision-making in this high-risk population. This work was supported by the Jikei University Research Fund.